Sign inGet started

Rosenblatt Michael

Insider CIK 1478797 · AXLA Director · RUBY Director · MRK Exec V-P & Chief Med Officer · BRKS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AZTA Azenta, Inc. A Award2024-02-122024-02-132,465$65.93 $162.5K13,042SEC↗
AZTA Azenta, Inc. A Award2023-02-132023-02-153,604— $010,577SEC↗
AXLA Axcella Health Inc. A Award deriv2022-05-192022-05-2340,000— $040,000SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2022-05-122022-05-1325,000— $025,000SEC↗
AZTA Azenta, Inc. A Award2022-02-112022-06-091,922— $06,973SEC↗
BRKS Brooks Automation, Inc. S Sale2021-11-122021-11-152,831$114.13 $323.1K5,051SEC↗
BRKS Brooks Automation, Inc. S Sale2021-05-132021-05-141,760$90.00 $158.4K7,882SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2021-05-122021-05-1325,000— $025,000SEC↗
BRKS Brooks Automation, Inc. A Award2021-02-052021-02-081,760— $09,642SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2020-05-212020-05-2625,000— $025,000SEC↗
BRKS Brooks Automation, Inc. A Award2020-02-112020-02-132,831— $07,882SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2019-05-232019-05-2825,000— $025,000SEC↗
BRKS BROOKS AUTOMATION INC A Award2019-02-082019-02-114,033— $05,051SEC↗
BRKS BROOKS AUTOMATION INC A Award2018-09-072018-09-111,018— $01,018SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2018-07-172018-07-1825,000— $025,000SEC↗
MRK Merck & Co., Inc. A Award deriv2016-05-102016-05-1250,934— $050,934SEC↗
MRK Merck & Co., Inc. A Award2016-02-222016-02-247,738$50.77 $392.9K41,133SEC↗
MRK Merck & Co., Inc. M Exercise deriv2015-05-022015-05-053,818$59.86 $228.5K0SEC↗
MRK Merck & Co., Inc. F Tax w/h2015-05-022015-05-051,980$59.86 $118.5K32,554SEC↗
MRK Merck & Co., Inc. M Exercise2015-05-022015-05-053,818— $034,534SEC↗
MRK Merck & Co., Inc. A Award deriv2015-05-012015-05-0546,440— $046,440SEC↗
MRK Merck & Co., Inc. A Award2015-02-232015-02-255,001$58.30 $291.6K30,477SEC↗
MRK Merck & Co. Inc. A Award deriv2014-05-092014-05-1341,265— $041,265SEC↗
MRK Merck & Co. Inc. M Exercise deriv2014-05-042014-05-064,103$58.22 $238.9K0SEC↗
MRK Merck & Co. Inc. M Exercise2014-05-042014-05-064,103— $026,720SEC↗
MRK Merck & Co. Inc. F Tax w/h2014-05-042014-05-061,799$58.22 $104.7K24,921SEC↗
MRK Merck & Co. Inc. A Award2014-02-242014-02-264,907$56.18 $275.7K22,439SEC↗
MRK Merck & Co. Inc. M Exercise deriv2013-05-072013-05-084,479$44.98 $201.5K0SEC↗
MRK Merck & Co. Inc. F Tax w/h2013-05-072013-05-082,323$44.98 $104.5K17,072SEC↗
MRK Merck & Co. Inc. M Exercise2013-05-072013-05-084,479— $019,395SEC↗
MRK Merck & Co. Inc. A Award deriv2013-05-062013-05-0848,309— $048,309SEC↗
MRK Merck & Co. Inc. A Award2013-02-252013-02-275,392$42.52 $229.3K14,776SEC↗
MRK Merck & Co. Inc. M Exercise deriv2013-02-192013-02-2015,000$41.42 $621.3K0SEC↗
MRK Merck & Co. Inc. F Tax w/h2013-02-192013-02-205,616$41.42 $232.6K9,384SEC↗
MRK Merck & Co. Inc. M Exercise2013-02-192013-02-2015,000— $015,000SEC↗
MRK Merck & Co. Inc. A Award deriv2012-05-022012-05-0454,845— $054,845SEC↗
MRK Merck & Co. Inc. A Award deriv2012-05-022012-05-043,818— $03,818SEC↗